Stockreport

Shinobi Strengthens Leadership to Propel Scalable Immune-Evasive Cell Therapies to the Clinic [Yahoo! Finance]

Century Therapeutics, Inc.  (IPSC) 
PDF Dr. Katy Rezvani and Dr. Georg Schett join Shinobi's world-class Scientific Advisory Board (SAB), alongside Dr. Carl June New appointments cap Shinobi's achievements [Read more]